Xavier Gabriela Monteiro Barbosa, Paes Yngrid Fernanda Oliveira, de Meneses Costa Ferreira Lindalva Maria, Lamarão Maria Louze Nobre, Silva Cecy Martins, Ribeiro-Costa Roseane Maria, Araújo Jesuina Lamartine Nogueira
Department of Restorative Dentistry, Faculty of Dentistry, Federal University of Pará, Av. Augusto Corrêa, nº 01, Belém, 66.075-110, PA, Brazil.
Pharmaceutical Nanotechnology Laboratory, Faculty of Pharmacy, Federal University of Pará, Av. Augusto Corrêa, nº 01, Belém, 66.075-110, PA, Brazil.
Clin Oral Investig. 2025 Mar 1;29(3):165. doi: 10.1007/s00784-025-06168-w.
This clinical study evaluated an experimental pregabalin (PG) gel in reducing dental sensitivity (DS) and color change after dental bleaching.
Seventy-five volunteers were selected and randomized into three groups: GPG (10% pregabalin gel), GKF (5% potassium nitrate and 2% sodium fluoride), and GP (placebo gel). Prior to the bleaching treatment, GPG and GKF received applications of the respective desensitizing gels for 10 min. The GP group received an application of placebo gel, similar to the other groups. The bleaching was performed with 35% hydrogen peroxide in 3 sessions, with a 7-day interval between sessions. Post-bleaching DS was assessed using the visual analog scale (VAS) over 21 days of follow-up. Color Assessment (ΔE00, ΔWID, and ΔEab) and luminosity (L) were measured at baseline (T0) and 7 days after the third session (T1). Friedman, Kruskal-Wallis, one-way ANOVA, and Tukey tests were used, with α = 5%.
Intergroup analysis showed that on the 1st, 8th, and 15th days, DS was higher for GP (p < 0.006; p = 0.004; p < 0.001) and did not differ between GKF and GPG (p = 0.203; p = 0.178; p = 0.09). In the intragroup analysis, GP showed a significant increase in DS on the 15th day (p < 0.001).
The experimental 10% pregabalin gel reduced dental sensitivity and did not interfere with bleaching results.
The topical application of 10% pregabalin gels and NKF was effective in reducing tooth sensitivity 24 hoursafter whitening with 35% hydrogen peroxide.
ClinicalTrials.gov trial registry with the identifier NCT06180707.
本临床研究评估了一种实验性普瑞巴林(PG)凝胶在减轻牙齿漂白后的牙齿敏感(DS)和颜色变化方面的效果。
选取75名志愿者并随机分为三组:GPG(10%普瑞巴林凝胶)、GKF(5%硝酸钾和2%氟化钠)和GP(安慰剂凝胶)。在漂白治疗前,GPG和GKF分别使用各自的脱敏凝胶10分钟。GP组使用与其他组类似的安慰剂凝胶。使用35%过氧化氢进行三次漂白治疗,每次治疗间隔7天。在21天的随访期间,使用视觉模拟量表(VAS)评估漂白后的牙齿敏感情况。在基线(T0)和第三次治疗后7天(T1)测量颜色评估(ΔE00、ΔWID和ΔEab)和亮度(L)。使用Friedman检验、Kruskal-Wallis检验、单因素方差分析和Tukey检验,α = 5%。
组间分析显示,在第1天、第8天和第15天,GP组的牙齿敏感程度更高(p < 0.006;p = 0.004;p < 0.001),GKF组和GPG组之间无差异(p = 0.203;p = 0.178;p = 0.09)。组内分析显示,GP组在第15天牙齿敏感程度显著增加(p < 0.001)。
实验性10%普瑞巴林凝胶可降低牙齿敏感,且不影响漂白效果。
10%普瑞巴林凝胶和NKF局部应用可有效减轻35%过氧化氢美白24小时后的牙齿敏感。
ClinicalTrials.gov试验注册库,标识符为NCT06180707。